October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its investigational heart failure medicine, LCZ696, was superior to the ACE-inhibitor enalapril on key endpoints. The results were released at the 2014 European Society of Cardiology (ESC) Congress and published simultaneously in the New England Journal of Medicine.

October 15, 2014 — Imaging can be a cost-effective way to identify people at risk for stroke who might benefit from aggressive intervention, according to a new modeling study published online in the journal Radiology.

Impact of Mental Stress on Heart Varies Between Men, Women ACC Study

Men and women have different cardiovascular and psychological reactions to mental stress, according to a study of men and women who were already being treated for heart disease.

The Geneva Healthcare Suite has been proven effective by clinicians at the Douglas & Nancy Barnhart Cancer Center at Sharp Chula Vista Medical Center in managing risk for patients with cardiac devices undergoing radiation therapy.

Healthline today launched its HealthData Engine to harness the power of structured and unstructured data to improve outcomes and reduce costs. The new big-data analytics platform leverages the company’s HealthTaxonomy advanced clinical natural language processing (NLP) technologies and semantic analysis to turn patient data into actionable insights.


In partnership with Intel-GE Care Innovations, Cigna-HealthSpring is expanding its population health program that utilizes interactive tablets – the Intel-GE Care Innovations Guide – and virtual connection to Cigna-HealthSpring nurse practitioners to partner and engage with patients diagnosed with congestive heart failure (CHF) to successfully manage their condition at home. Based on a successful pilot in Middle Tennessee that engaged 50 patients, the innovative remote patient management program is now being implemented with 250 patients statewide with potential for further expansion.

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating and preventing heart failure. The newly discovered molecule provides the heart with a tool to block a protein that orchestrates genetic disruptions when the heart is subjected to stress, such as high blood pressure.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now